A DUNFERMLINE-BASED company has celebrated its 30th anniversary with the news of a 14 per cent growth last year.

Optos, a specialist in advanced retinal imaging technology, was founded in 1992 with the goal to make a patient-friendly device to capture an ultra-widefield image of the retina.

It was set up by Douglas Anderson after his five-year-old son lost his sight in one eye due to a retinal detachment despite regular eye examinations.

Determined to enable eye problems to be detected as early as possible, he set out with the goal to make a patient-friendly device to capture an ultra-widefield image of the retina. Through this, Optos developed a device capable of ultra-widefield (UWF™) high resolution digital images called optomap.

Since then, more than 500 million optomap® images have been captured using Optos technology on devices across the world.

Globally, more than 500 people are now employed by Optos in a variety of roles while more than 2,000 published and ongoing clinical trials have also been conducted.

Rob Kennedy, CEO of Optos, is proud of Optos' achievements over the past three decades.

"We have remained true to Douglas’s core purpose of improving patient outcomes by providing the best imaging technology and so reduce the risk of sight loss," he said.

"In pursuit of this purpose, we pioneered the only single-capture ultra-widefield (UWF™) retinal imaging, and now more than 22,000 optomap® devices are in use worldwide.

"We have delivered significant growth, continued to develop our technology, and ultimately enabled our customers to help save the sight of their patients.

“I want to thank all the Optos team for their innovation and hard work over the last 30 years. It’s this dedication and commitment that has helped shape Optos to become the business it is today and we look forward to continuing to push the boundaries in support of our customers and their patients.”